Equillium raises $35 million from RA Capital Management Mar 13, 2026 08:01AM
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 11, 2026 04:43PM
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 10, 2026 04:39PM
Relmada Therapeutics raises $160 million in oversubscribed private placement Mar 9, 2026 07:05AM
Solid Biosciences raises $240 million in private placement Mar 6, 2026 08:31AM
View Older Stories

Mar 2, 2026 04:25PM Form SCHEDULE 13D/A Bicara Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 2, 2026 08:01AM Rallybio and Candid Therapeutics announce merger agreement
Feb 18, 2026 08:01AM Sensei Biotherapeutics acquires Faeth Therapeutics for $200 million
Feb 17, 2026 07:29PM Form SCHEDULE 13D/A Evommune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 07:22PM Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:46PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:44PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:42PM Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:41PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:39PM Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:37PM Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:34PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 17, 2026 04:30PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:26PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:24PM Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:22PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:20PM Form SCHEDULE 13G/A Arcellx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:18PM Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:16PM Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 04:05PM Immunic closes $200 million private placement financing
Feb 13, 2026 06:30AM Immunic raises up to $400 million in oversubscribed private placement
Feb 10, 2026 07:06AM Sutro Biopharma prices $110 million stock offering at $13.98 per share
Feb 9, 2026 05:02PM Form SCHEDULE 13G ALX ONCOLOGY HOLDINGS Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 2, 2026 04:30PM Form SCHEDULE 13G Helix Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 30, 2026 08:31AM ALX Oncology prices $150 million stock and warrant offering
Jan 16, 2026 04:35PM Form SCHEDULE 13G Century Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 9, 2026 04:45PM Form SCHEDULE 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 8, 2026 08:01AM Century Therapeutics raises $135 million in private placement
Jan 7, 2026 04:53PM Form SCHEDULE 13G Disc Medicine, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 23, 2025 04:01PM Vor Bio adds RA Capital and Forbion partners to board
Dec 18, 2025 06:31PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 18, 2025 06:07PM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 18, 2025 05:23PM Form SCHEDULE 13G Rezolute, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 15, 2025 07:56PM Form SCHEDULE 13D/A Climb Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 15, 2025 05:05PM Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 15, 2025 08:01AM Vor Bio raises $150 million in private placement for drug development
Dec 12, 2025 05:14PM Form SCHEDULE 13D Perceptive Capital Solut Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 10, 2025 04:44PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 3, 2025 04:22PM Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 17, 2025 04:44PM Form SCHEDULE 13D Evommune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 17, 2025 04:39PM Form SCHEDULE 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 06:13PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 04:26PM Form SCHEDULE 13G/A Tourmaline Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 04:26PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 04:25PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 04:23PM Form SCHEDULE 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2025 04:21PM Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
View Older Stories